D051217Chemicals & DrugsD12.776.260.750D12.776.543.750.705.910.500.90015200.987675Toll-Like Receptor 9prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAnesthesia and Critical CareMedicine-RheumatologyAaronEsser-KahnAaron Esser-Kahn41.7886000000000087.598699999999993755Esser-Kahn, AaronProfessorPritzker Institute for Molecular Engineering34326162Ribas A, Medina T, Kirkwood JM, Zakharia Y, Gonzalez R, Davar D, Chmielowski B, Campbell KM, Bao R, Kelley H, Morris A, Mauro D, Wooldridge JE, Luke JJ, Weiner GJ, Krieg AM, Milhem MMCancer discoveryOvercoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma. Cancer Discov. 2021 12 01; 11(12):2998-3007.Cancer Discov2021-12-01T00:00:002021Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.24053111Torres-García D, Cruz-Lagunas A, García-Sancho Figueroa MC, Fernández-Plata R, Baez-Saldaña R, Mendoza-Milla C, Barquera R, Carrera-Eusebio A, Ramírez-Bravo S, Campos L, Angeles J, Vargas-Alarcón G, Granados J, Gopal R, Khader SA, Yunis EJ, Zuñiga JJournal of translational medicineVariants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population. J Transl Med. 2013 Sep 21; 11:220.J Transl Med2013-09-21T00:00:002013Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population.0.4718030.018871115research area of0.8511920.076426318subject area forhttps://voices.uchicago.edu/clarklab/Clark LaboratoryMedicineUniversity of ChicagoRichaDhawanRicha Dhawan41.78927490000000-87.601250000000001405Dhawan, RichaAssociate ProfessorMarkChaneyMark Chaney41.78927490000000-87.601250000000001546Chaney, MarkProfessorMaria-LuisaAlegre2mNlDqYHHMzMknJtY0fp/Cv/+94=Maria-Luisa Alegre41.78927490000000-87.60125000000000481Alegre, Maria-LuisaProfessorMarcus RamsayClarkMarcus Ramsay Clark41.78927490000000-87.60125000000000625Clark, Marcus RamsayProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor24169824Hossain DM, Dos Santos C, Zhang Q, Kozlowska A, Liu H, Gao C, Moreira D, Swiderski P, Jozwiak A, Kline J, Forman S, Bhatia R, Kuo YH, Kortylewski MBloodLeukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity. Blood. 2014 Jan 02; 123(1):15-25.Blood2013-10-29T00:00:002013Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.24651487Veselits M, Tanaka A, Lipkowitz S, O'Neill S, Sciammas R, Finnegan A, Zhang J, Clark MRPloS oneRecruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes. PLoS One. 2014; 9(3):e89792.PLoS One2014-03-20T00:00:002014Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes.22045986Kim YH, Gratzinger D, Harrison C, Brody JD, Czerwinski DK, Ai WZ, Morales A, Abdulla F, Xing L, Navi D, Tibshirani RJ, Advani RH, Lingala B, Shah S, Hoppe RT, Levy RBloodIn situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Blood. 2012 Jan 12; 119(2):355-63.Blood2011-11-01T00:00:002011In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.